share_log

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Marriott Tina

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Marriott Tina

Recursion Pharmaceuticals | 4：持股变动声明-高管 Marriott Tina
美股sec公告 ·  04/29 18:45
Moomoo AI 已提取核心信息
Tina Marriott, President and COO of Recursion Pharmaceuticals, completed a sale of 3,000 shares of the company's Class A Common Stock on April 25, 2024. The shares were sold at a price of $7.6735 per share, resulting in a total transaction value of $23,020.50. Prior to this transaction, Marriott exercised options to acquire the same number of shares at $1.06 each. Following the sale, Marriott's direct holdings in Recursion Pharmaceuticals amount to 543,231 shares. The transactions were carried out as open market operations.
Tina Marriott, President and COO of Recursion Pharmaceuticals, completed a sale of 3,000 shares of the company's Class A Common Stock on April 25, 2024. The shares were sold at a price of $7.6735 per share, resulting in a total transaction value of $23,020.50. Prior to this transaction, Marriott exercised options to acquire the same number of shares at $1.06 each. Following the sale, Marriott's direct holdings in Recursion Pharmaceuticals amount to 543,231 shares. The transactions were carried out as open market operations.
Recursion Pharmicals总裁兼首席运营官蒂娜·万豪于2024年4月25日完成了该公司3,000股A类普通股的出售。这些股票以每股7.6735美元的价格出售，总交易价值为23,020.50美元。在本次交易之前，万豪行使了期权，以每股1.06美元的价格收购了相同数量的股份。出售后，万豪在Recursion Pharmicals的直接持股量为543,231股。这些交易是以公开市场操作的形式进行的。
Recursion Pharmicals总裁兼首席运营官蒂娜·万豪于2024年4月25日完成了该公司3,000股A类普通股的出售。这些股票以每股7.6735美元的价格出售，总交易价值为23,020.50美元。在本次交易之前，万豪行使了期权，以每股1.06美元的价格收购了相同数量的股份。出售后，万豪在Recursion Pharmicals的直接持股量为543,231股。这些交易是以公开市场操作的形式进行的。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息